Seagull Technologies

Seagull Technologies has developed a novel cross-platform drug delivery method thatnon-invasively delivers drugs ranging from small molecules to large proteins (withor without nano-particle encapsulation) through biological tissues by an innovativecombination of nanotechnology and ultrasound.

The technology:

removes the risks and discomfort associated with injections;

depending on the site of application, can be used for targeted or systemic drug delivery; and

may offer new opportunities for drugs that are inactivated by gastro-intestinal or liver metabolism; or cause untoward side effects from ingestion